Novartis Pharmaceuticals Corporation lists 92 NDCs in the CMS NADAC file (0 generic, 92 brand), at an average NADAC of $767.89 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
92
0G / 92B
Avg Price / Unit
$767.8870
$0.44 – $24413.74
Avg 7d Change
0.00%
Across 32 drugs with changes
7d Activity
19↑13↓60 flat
of 92 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
How many drugs does Novartis Pharmaceuticals Corporation make?
Novartis Pharmaceuticals Corporation lists 92 NDCs in the CMS NADAC file — 0 generic and 92 brand products.
What is the average price of Novartis Pharmaceuticals Corporation drugs?
The average NADAC across Novartis Pharmaceuticals Corporation's portfolio is $767.8870 per unit, ranging from $0.4362 to $24413.7438.
What types of drugs does Novartis Pharmaceuticals Corporation make?
Novartis Pharmaceuticals Corporation makes drugs across 24 FDA pharmacologic classes. The most common by NDC count are Angiotensin 2 Receptor Blocker (25), Central Nervous System Stimulant (17), Calcium Channel Blocker (13), Dihydropyridine Calcium Channel Blocker (13), Kinase Inhibitor (10).
Has Novartis Pharmaceuticals Corporation had any drug recalls?
7 FDA recalls are matched to Novartis Pharmaceuticals Corporation in the openFDA feed, most recently on Aug 4, 2026.
How has Novartis Pharmaceuticals Corporation's pricing changed recently?
Over the past 7 days, 19 Novartis Pharmaceuticals Corporation products rose and 13 fell, with a portfolio-wide average change of +0.0%.
Xiidra (lifitegrast ophthalmic solution) 5%, packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 54092-606-01) and b) 5-Single-Use Containers (NDC 54092-606-06), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.
Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-95) and b) 4 pouches x 5 single-use containers (NDC 0078-0911-94), Rx Only, Manufactured by: The Ritedose Corporation Columbia, SC 29203; Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936.
Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 54092-606-07) and b) 4 pouches x 5 single-use containers (NDC 54092-606-04), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.